欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/3865/002
药品名称Methylphenidathydrochlorid Mylan 36 mg Retardtabletten
活性成分
    • Methylphenidate 28.44 mg
剂型Prolonged-release tablet
上市许可持有人Mylan Germany GmbH Luetticher Strasse 5 53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
Methylphenidathydrochlorid Mylan 36 mg Retardtablette
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Methylphenidate Retard Viatris 36mg tabletten met verlengde afgifte
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
许可日期2014/05/12
最近更新日期2025/01/22
药物ATC编码
    • N06BA04 methylphenidate
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase